AI's Growing Role in Clinical Trials Depends on Skilled Implementation
Artificial intelligence is being integrated across clinical trials for drug discovery, patient selection, protocol design, and data management. The technology shows particular promise for rare disease research through AI-powered artificial twins that could replace traditional placebo controls. However, experts emphasize that AI tools are only effective when properly implemented by trained personnel who prioritize patient outcomes over technological advancement.
Artificial intelligence is transforming clinical trial operations at nearly every stage, from identifying drug targets and eligible patients to generating trial protocols and managing documentation. AI can analyze billions of data points, mine electronic health records, monitor patient responses through voice and video analysis, and process medical imaging faster and more consistently than traditional methods. A particularly promising application is AI-powered artificial twins for rare disease research, which model disease progression to create personalized control arms, potentially allowing single-trial efficacy data for FDA approval. However, the Forbes article emphasizes that successful AI implementation requires more than technological capability—it demands skilled researchers, trained staff, rigorous data analysis protocols, and a fundamental commitment to improving patient outcomes rather than simply generating impressive data.
What different sources said
- ForbesCenter
AI In Clinical Trials: Technology Is Only As Good As The People Behind It
Related
States Report Significant ACA Coverage Losses as Enhanced Subsidies Expire
Several states are experiencing major coverage losses under the Affordable Care Act as enhanced federal subsidies have not been renewed by Congress. Monthly enrollment data through April from six states shows substantial cancellations and unpaid premiums following 2026 sign-ups, according to Georgetown University analysis. The trend suggests the impact of subsidy expiration may be more severe than previously estimated.
Artificial Turf Contains Hundreds of Chemicals; Health Risks Remain Unclear
Artificial turf fields contain approximately 400 chemicals, some linked to cancer and hormone disruption, raising health concerns among athletes and communities. FIFA has banned synthetic turf from World Cup matches due to established injury risks and extreme surface temperatures. The actual health danger to players and users remains scientifically uncertain despite the chemical presence.
Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction
Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.